ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,420.26
-0.22%
Dow Jones
40,003.59
0.34%
Gold vs US Dollar
2,413.935
1.50%
Brent Oil
83.76
0.00%
Bitcoin
67,080.76
0.00%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Annovis Bio Inc (ANVS)

  7. Annovis Bio Inc (ANVS) News

Annovis Bio (ANVS)

Annovis Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:ANVS
DateTimeSourceHeadlineSymbolCompany
13/05/202421:05Edgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
13/05/202412:30GlobeNewswire Inc.Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial ResultsNYSE:ANVSAnnovis Bio Inc
10/05/202422:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ANVSAnnovis Bio Inc
09/05/202421:03Edgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
09/05/202412:30GlobeNewswire Inc.Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s DiseaseNYSE:ANVSAnnovis Bio Inc
06/05/202422:12Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:ANVSAnnovis Bio Inc
06/05/202422:11Edgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
06/05/202412:30GlobeNewswire Inc.Annovis Bio CEO Maria Maccecchini Issues Letter to StockholdersNYSE:ANVSAnnovis Bio Inc
29/04/202415:10GlobeNewswire Inc.Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s DiseaseNYSE:ANVSAnnovis Bio Inc
02/04/202412:30GlobeNewswire Inc.Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial ResultsNYSE:ANVSAnnovis Bio Inc
28/02/202412:08IH Market NewsUS Stock Movers Before Market: Beyond Meat, eBay, First Solar, Urban Outfitters…NYSE:ANVSAnnovis Bio Inc
12/02/202419:00Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NYSE:ANVSAnnovis Bio Inc
01/02/202421:05Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NYSE:ANVSAnnovis Bio Inc
22/11/202321:27Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:ANVSAnnovis Bio Inc
22/11/202321:24Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:ANVSAnnovis Bio Inc
22/11/202321:21Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:ANVSAnnovis Bio Inc
22/11/202321:14Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:ANVSAnnovis Bio Inc
21/11/202319:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ANVSAnnovis Bio Inc
21/11/202319:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ANVSAnnovis Bio Inc
21/11/202319:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ANVSAnnovis Bio Inc
21/11/202319:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ANVSAnnovis Bio Inc
08/11/202321:45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ANVSAnnovis Bio Inc
02/11/202311:30Business WireAnnovis Bio Measures Novel Biomarkers in Plasma of Parkinson’s PatientsNYSE:ANVSAnnovis Bio Inc
01/11/202316:28Edgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
01/11/202316:24Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:ANVSAnnovis Bio Inc
31/10/202312:00Business WireAnnovis Bio Announces Pricing of $7.5 Million Public OfferingNYSE:ANVSAnnovis Bio Inc
30/10/202321:27Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:ANVSAnnovis Bio Inc
30/10/202321:17Edgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
30/10/202320:48Business WireAnnovis Bio Announces Launch of Proposed Public OfferingNYSE:ANVSAnnovis Bio Inc
30/10/202320:42Business WireAnnovis Bio Receives Positive Recommendation to Continue Phase 2/3 Trial of Buntanetap for Alzheimer’s Disease Patients From the Independent Data and Safety Monitoring Board (DSMB)NYSE:ANVSAnnovis Bio Inc
 Showing the most relevant articles for your search:NYSE:ANVS

Your Recent History

UNSW
CHERRYETH
Cherry
LSE
JR.
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved